Results 131 to 140 of about 1,229,168 (350)

Phenolic Profile and Bioactive Prospects of Wild Annona Species From Angola

Chemistry &Biodiversity, EarlyView.
ABSTRACT Annona species (Annonaceae family) are valued for their nutritional and medicinal importance, especially in traditional medicine. This study investigated the phenolic profiles of the Angolan Annona muricata, Annona squamosa, and Annona senegalensis leaves, stem barks, and seeds hydroethanolic, infusion, and decoction extracts, also evaluating ...
Josefa Rangel, Ângela Liberal, Tiane C. Finimundy, Tânia S. P. Pires, Pedro Cravo, Maria Conceição Silva, Gustavo Capatti Cassiano, Lillian Barros, Maria M. Romeiras, Ângela Fernandes   +9 more
wiley   +1 more source

Bactericidal Action of Gatifloxacin, Rifampin, and Isoniazid on Logarithmic- and Stationary-Phase Cultures of Mycobacterium tuberculosis

, 2005
C N Paramasivan, S. Sulochana, G Kubendiran, Prem Venkatesan, D.A. Mitchison   +4 more
openalex   +1 more source

Rapid molecular detection of tuberculosis and rifampin resistance.

New England Journal of Medicine, 2010
C. Boehme, P. Nabeta, D. Hillemann, M. Nicol, S. Shenai, F. Krapp, J. Allen, Rasim Tahirli, R. Blakemore, R. Rustomjee, A. Milovic, Martin Jones, S. M. O’Brien, D. Persing, S. Ruesch-Gerdes, E. Gotuzzo, C. Rodrigues, D. Alland, M. Perkins   +18 more
semanticscholar   +1 more source

PharmVar GeneFocus: NAT2—Genetic Variation and Updated Nomenclature

Clinical Pharmacology &Therapeutics, EarlyView.
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human N‐acetyltransferase 2 (NAT2) gene. NAT2 metabolizes several clinically used drugs including isoniazid, hydralazine, amifampridine, procainamide, and sulfonamides such as dapsone, and also some highly carcinogenic arylamines.
Georgia Papanikolaou, Estella S. Poloni, José A.G. Agúndez, Raquel L.F. Teixeira, Erin C. Boone, Adalberto Rezende Santos, Michelle Whirl‐Carrillo, Katrin Sangkuhl, Teri E. Klein, Mariam R. Habil, Giannoulis Fakis, Rodney F. Minchin, David W. Hein, Sotiria Boukouvala, Andrea Gaedigk   +14 more
wiley   +1 more source

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

New England Journal of Medicine, 2001
J. Keane, Sharon K. Gershon, R. Wise, E. Mirabile-Levens, J. Kasznica, W. Schwieterman, J. Siegel, M. Braun   +7 more
semanticscholar   +2 more sources

Improving Genotype Imputation in High‐Dimensional Pharmacogenomics Using Multiple Imputation: Evaluation with Machine Learning Approaches

Clinical Pharmacology &Therapeutics, EarlyView.
Multiple imputation is well‐established for handling missing data, yet its use in high‐dimensional genetic datasets remains limited. Using pharmacokinetic tuberculosis simulations and SNP data (1000 Genomes Project), we compared machine learning (ML) and traditional approaches (e.g., mean imputation and complete‐case analysis) for imputation and ...
Innocent G. Asiimwe, Tao You, Daniel F. Carr, Munir Pirmohamed, Geraint Davies, Andrea L. Jorgensen, on behalf of the UNITE4TB Consortium   +6 more
wiley   +1 more source

The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis

, 2012
January Weiner, Jeroen Maertzdorf, Stefan H. E. Kaufmann   +2 more
openalex   +2 more sources

QuantiFERON-TB Testing for Latent Tuberculosis Infection in Low-Prevalence Countries: Making the Most of an Imperfect Process [PDF]

, 2011
W. Schneider, Arthur E. Brown, Cynthia Eisenstein   +2 more
openalex   +1 more source

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Clinical Infectious Diseases, 2016
P. Nahid, S. Dorman, N. Alipanah, P. Barry, J. Brożek, A. Cattamanchi, L. H. Chaisson, R. Chaisson, C. Daley, M. Grzemska, J. Higashi, Christine S. Ho, P. Hopewell, S. Keshavjee, C. Lienhardt, R. Menzies, C. Merrifield, M. Narita, R. O'brien, C. Peloquin, A. Raftery, J. Saukkonen, H. S. Schaaf, G. Sotgiu, J. Starke, G. Migliori, A. Vernon   +26 more
semanticscholar   +1 more source

Comprehensive Review on the Occurrence of Aflatoxin M1 in Milk, Prevalent Health Issues Associated With It, and Innovative Strategies for Mitigation of Aflatoxin M1 in Processed Milk

Food Safety and Health, EarlyView.
Aflatoxins, carcinogenic compounds in milk; reduction strategies such as thermal deactivation, UV light exposure, ionizing radiation, and solvent extraction. ABSTRACT Aflatoxins (AFs) are known to be cancer causing substances recognized within milk along with the milk goods.
Akshay Ramani, Tanmay Hazra, Anamika Das, Subhadip Manik, Ayon Tarafdar, Swarnima Dey, Umesh Singh   +6 more
wiley   +1 more source